Skip to main content
The BMJ logoLink to The BMJ
. 1990 Jun 30;300(6741):1694–1695. doi: 10.1136/bmj.300.6741.1694-a

Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs.

D I Evans 1, A Shaw 1
PMCID: PMC1663310  PMID: 2143948

Full text

PDF
1694

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gazengel C., Courouce A. M., Torchet M. F., Kremp O., Brangier J., Brechot C., Degos F. Use of HBV vaccine in hemophiliacs. Scand J Haematol Suppl. 1984;40:323–328. doi: 10.1111/j.1600-0609.1984.tb02580.x. [DOI] [PubMed] [Google Scholar]
  2. Hedner U., Hansson B. G., Vermylen J., Verstraete M., Colaert J., Desmyter J. Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden. Scand J Haematol Suppl. 1984;40:317–321. [PubMed] [Google Scholar]
  3. Janco R. L. Immunogenicity of subcutaneous hepatitis B vaccine in hemophiliacs. J Pediatr. 1985 Aug;107(2):316–316. doi: 10.1016/s0022-3476(85)80168-2. [DOI] [PubMed] [Google Scholar]
  4. Mannucci P. M., Zanetti A. R., Gringeri A., Tanzi E., Morfini M., Messori A., Tirindelli M. C., de Biasi R., Ciavarella N., Colombo M. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med. 1989 Jun;149(6):1333–1337. [PubMed] [Google Scholar]
  5. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES